Login
Toggle navigation
Videos
Categories
Trending
Recently, Liu Chunhe, CEO of Newborn Town, discussed business developments without further details provided in the text.
00:10:00
Watch Full Video
×
Please Login to watch Full video
Login
+ ADD TO Wishlist
×
Please login
Login
Share On Facebook
Share On Twitter
Ping Li - CEO & Co-Founder - Newborn Town
Recent Videos
00:17:08
Urasar is 100% Hayasa Metals Inc. owned; our exploration license over the Urasar mineral district
00:10:00
Dryden Gold Secures $20M+ War Chest, Delivers High-Grade Discoveries and Expands Drill Targets Across Gold Rock District|Trey Wasser,CEO & Director,Dryden Gold 1
00:10:00
Mitchell Services Targets $50–60M EBITDA as Rig Utilization Drives Earnings Upside| Andrew Elf,CEO,Mitchell Services Limited
00:10:00
Lomiko Metals Reports Strong Pre-Feasibility Results with $800M NPV, Advancing High-Growth Graphite Projects|Gordana Slepcev,CEO,Lomiko Metals Inc.4
00:10:00
Generative AI Meets Wet Lab: Absci Accelerates Biologic Development with Hybrid Business Model|Sean McClain,CEO,Absci
00:10:00
Obliva Aims to Transform Lives of Children with Rare Mitochondrial Disorders|Ellen K. Donnelly ,CEO,Abliva AB7
00:10:00
Abionic Repositions Bio-HDL Therapy CCR001 for Rare Kidney and Eye Disorders with Promising Early Results|Cyrille Tupin,CEO,ABIONYX Pharma
00:10:00
Abingdon Health Reports 45% H1 Revenue Growth Amid Strategic Expansion and Large Contract Wins|Dr Chris Hand,Chairman,Abingdon Health
00:10:00
EB-101 Gene Therapy Shows Promising Results in Treating Recessive Dystrophic EB|Vishwas Seshadri,CEO,Abeona Therapeutics
00:10:00
Revolutionizing Trauma Care: How AAP’s Silver Technology is Fighting Deadly Implant Infections|Rubino Di Girolamo,CEO,aap Implantate AG
00:10:00
Revolutionizing Cancer Treatment: Tumor-Agnostic mTOR Targeting Shows Breakthrough Success in Rare and Genetic-Driven Tumors| Neil Desai, Founder, Executive Chairman ,Aadi Bioscience
00:10:00
Millions Affected, No Approved Cure: 89bio Advances New Therapy for NASH|Rohan Palekar,CEO,89bio Inc2
00:10:00
Malaria Prevention Drug Arakoda Positioned to Drive Future Growth for 60 Degrees Pharmaceuticals|Geoffrey Dow,President,60 Degrees Pharmaceuticals
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4basebio CEO Heikki Lanckriet Unveils Vision for Next-Generation Synthetic DNA and Gene Therapy Components|Heikki Lanckriet,CEO,4basebio
Suggestions
00:10:00
Understanding Bitcoin: Insights from a Financial Advisor - Phil Francois, CFP | PHILIP FRANCOIS - CERTIFIED FINANCIAL PLANNER, Owner & Financial Planner of Foundation Wealth Planning
00:10:00
Jobs in Lifting: Columbus McKinnon Corporation - For Veterans and Newcomers | David J. Wilson, CEO, Columbus McKinnon CorpVC3:BER
00:10:00
Conglomerate-Hosted Gold Project Presentation by Inventus CEO at Mining Conference
00:00:00
ProMIS Neurosciences reckons it has the only assets to tackle - Eugene William , Promis Neurosciences Inc
00:10:00
May 2020 Webinar Clip: Sound Financial Planning with Nathan Mersereau | Nathan Mersereau, President, Planning Alternatives Ltd.
00:10:00
Introducing YESCan: Streamlining Fenestration Product Data Submission to NRCan | Valmor Ruscheck - CEO of Natural Resources Canada
00:10:00
Phunware CEO Alan Knitowski announces the formal closure of the acquisition of privately-held Lyte Technology, Inc. in an interview with Proactive.
00:00:00
Vered Caplan, CEO at Orgenesis Inc.
00:10:00
Recycling in the Battery Industry: Technological Advancements and Economic Viability
00:10:00
Expanding Beyond Borders: Insights from Kate Root of Chesapeake Bank on Merchant Payment Solutions | Kate Root - Senior Vice President & Managing Director, Chesapeake Payment Systems
00:10:00
Unlocking Investment Potential: A Conversation with Kingdom Holding CEO Talal Ibrahim Al-Mayman | Eng. Talal Ibrahim Almaiman, CEO, Kingdom Holding Company.
00:10:00
Revolutionizing Healthcare: From Genomes to Therapeutic Modalities | Jean M. Hynes, CEO , Wellington Management Company.